Breaking Down Fulcrum Therapeutics: 7 Analysts Share Their Views
Breaking Down Fulcrum Therapeutics: 7 Analysts Share Their Views
深入探讨Fulcrum Therapeutics：7位分析师分享他们的观点
A comprehensive examination of...In the preceding three months, 7 analysts have released ratings for Fulcrum Therapeutics (NASDAQ:FULC), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月中，7位分析师公布了Fulcrum Therapeutics（纳斯达克股票代码：FULC）的评级，提出了从看涨到看跌的各种观点。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天中情绪的变化，并将其与前几个月进行了比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $9.0, a high estimate of $23.00, and a low estimate of $2.00. A 42.57% drop is evident in the current average compared to the previous average price target of $15.67.
分析师12个月目标股价的见解已经公布，平均目标股价为9.0美元，最高估计为23.00美元，低估值为2.00美元。与之前的平均目标股价15.67美元相比，目前的平均价格下降了42.57％。
Decoding Analyst Ratings: A Detailed Look
解码分析师评级：详细介绍
A comprehensive examination of...
对金融专...
登录免费看全文
登录/注册
资讯热榜
更新时间